Capasso, Anna
 Distribuzione geografica
Continente #
EU - Europa 233
NA - Nord America 153
AS - Asia 17
AF - Africa 3
Totale 406
Nazione #
US - Stati Uniti d'America 149
IT - Italia 114
IE - Irlanda 53
SE - Svezia 21
FR - Francia 10
DE - Germania 9
FI - Finlandia 8
CZ - Repubblica Ceca 5
CN - Cina 4
IN - India 4
KR - Corea 4
NL - Olanda 4
CA - Canada 3
SG - Singapore 3
BE - Belgio 2
BT - Bhutan 2
CI - Costa d'Avorio 2
RU - Federazione Russa 2
AT - Austria 1
CH - Svizzera 1
GB - Regno Unito 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 406
Città #
Dublin 49
Rome 49
Ashburn 34
Chandler 26
New York 24
Milan 12
Palermo 6
Helsinki 5
Marseille 5
Brno 4
Seoul 4
Amsterdam 3
Boardman 3
Boston 3
Bremen 3
Caorle 3
Grottaferrata 3
Houston 3
Princeton 3
Ronciglione 3
Seattle 3
Toronto 3
Trieste 3
Abidjan 2
Beijing 2
Bengaluru 2
Busto Arsizio 2
Cagliari 2
Ciserano 2
Frankfurt am Main 2
Kazan' 2
Lappeenranta 2
Liège 2
Padova 2
Paris 2
Pune 2
Reggio Emilia 2
Ronchis 2
Salò 2
San Mateo 2
Shanghai 2
Singapore 2
Thimphu 2
Washington 2
Andover 1
Brdo 1
Capoterra 1
Civitavecchia 1
Durban 1
Jarrow 1
Kragujevac 1
Krakow 1
Leawood 1
Los Angeles 1
Lugano 1
Mantova 1
Naaldwijk 1
Ranica 1
Sant'Agostino 1
Teramo 1
Vienna 1
Totale 313
Nome #
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 67
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 62
Assessing floppy infants: a new module 52
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 50
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 49
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 30
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 22
Long term follow-up of scoliosis progression in type II SMA patients 17
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 17
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 16
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 13
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 10
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 6
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 4
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? 4
Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data 4
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 4
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 2
Early treatment of type II SMA slows rate of progression of scoliosis 2
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 2
Totale 433
Categoria #
all - tutte 2.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 0 1 3 3 22
2022/2023153 14 16 4 11 5 7 20 16 14 5 15 26
2023/2024251 9 39 14 17 11 45 54 10 7 20 25 0
Totale 433